Public trial
RBR-8n8csf Effect of Mesenchymal stem cells in patients with decompensated cirrhosis
Date of registration: 08/26/2020 (mm/dd/yyyy)Last approval date : 08/26/2020 (mm/dd/yyyy)
Study type:
Interventional
Scientific title:
en
Bone marrow mesenchymal stem cells in acute-on-chronic liver failure grades 2 and 3: a phase I-II randomized clinical trial
pt-br
Uso de células tronco mesenquimais em pacientes com acute-on-chronic liver failure
Trial identification
- UTN code: U1111-1254-7100
-
Public title:
en
Effect of Mesenchymal stem cells in patients with decompensated cirrhosis
pt-br
Efeito das células tronco em pacientes com cirrose descompensada
-
Scientific acronym:
-
Public acronym:
-
Secondaries identifiers:
-
92330718.0.0000.5327
Issuing authority: Plataforma Brasil
-
20180643
Issuing authority: Comitê de Ética em Pesquisa do Hospital de Clínicas de Porto Alegre
-
92330718.0.0000.5327
Sponsors
- Primary sponsor: Hospital de Clínicas de Porto Alegre
-
Secondary sponsor:
- Institution: Hospital de Clínicas de Porto Alegre
-
Supporting source:
- Institution: Fundo de Incentivo à Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre
Health conditions
-
Health conditions:
en
Fibrosis and cirrhosis of liver
pt-br
Fibrose e cirrose hepáticas
-
General descriptors for health conditions:
en
K00-K93 XI - Diseases of the digestive system
pt-br
K00-K93 XI - Doenças do aparelho digestivo
-
Specific descriptors:
Interventions
-
Interventions:
en
Experimental group: 4 patients with grades 2 and 3 acute-on-chronic liver failure who will receive bone marrow-derived mesenchymal stem cells associated with standard medical treatment. Control group: 5 patients with grades 2 and 3 acute-on-chronic liver failure who will receive 0.9% saline solution associated with standard medical treatment
pt-br
Grupo experimental: 4 pacientes com acute-on-chronic liver failure de graus 2 e 3 que receberão células tronco mesenquimais derivadas da medula óssea associado ao tratamento médico padrão. Grupo controle: 5 pacientes com acute-on-chronic liver failure de graus 2 e 3 que receberão solução de salina a 0,9% associado ao tratamento médico padrão
-
Descriptors:
en
A11.329.830.500 Mesenchymal Stem Cells
pt-br
A11.329.830.500 Células-Tronco Mesenquimais
es
A11.329.830.500 Células Madre Mesenquimatosas
Recruitment
- Study status: Data analysis completed
-
Countries
- Brazil
- Date first enrollment: 09/01/2018 (mm/dd/yyyy)
-
Target sample size: Gender: Minimum age: Maximum age: 9 - 18 Y 70 Y -
Inclusion criteria:
en
fulfilling ACLF diagnostic criteria and ACLF grade 2 or 3
pt-br
Preencher critérios diagnósticos de ACLF e ter graus 2 ou 3
-
Exclusion criteria:
en
patient’s or family member’s refusal; (b) hepatocellular carcinoma (HCC); (c) formal contraindicationfor liver transplantation (e.g. advanced heart or pulmonary disease); (d) pregnancy and lactation; (e) previous liver transplantation; (f) HIV co-infection; (g) ACLF grade 1; (h) patients admitted for elective procedures; (i) renal chronic disease requiring dialysis.
pt-br
Recusa do paciente ou familiar; Carcinoma hepatocelular; Contraindicação ao transplante hepático; gravidez ou lactação; co-infecção pelo HIV; ACLF grau 1; pacientes admitidos para procedimentos eletivos; doença renal crônica com necessidade de diálise
Study type
-
Study design:
-
Expanded access program Purpose Intervention assignment Number of arms Masking type Allocation Study phase Treatment Parallel 2 Double-blind Randomized-controlled 1-2
Outcomes
-
Primary outcomes:
en
Evaluate mortality in the period of 28 and 90 days, verified by means of the Kaplain-Meier curves, from the observation of a variation post-intervention
pt-br
Avaliar a mortalidade no período de 28 e 90 dias, verificado por meio das curvas de Kaplain-Meier, a partir da constatação de uma variação pós-intervenção
en
Assess adverse effects, verified through clinical changes and vital signs, based on the observation of a post-intervention variation
pt-br
Avaliar os efeitos adversos, verificado por meio das alterações clínicas e de sinais vitais, a partir da constatação de uma variação pós-intervenção
-
Secondary outcomes:
en
Evaluate liver function patterns (prothrombin time, bilirubins and albumin) and inflammatory markers (total leukocytes and C-reactive protein) in the pre- and post-infusions of mesenchymal stem cells compared to placebo
pt-br
Avaliar os padrões de função hepática (tempo de protrombina, bilirrubinas e albumina) e marcadores inflamatórios (leucócitos totais e proteína C reativa) no período pré e pós-infusões de células tronco mesenquimais comparativamente ao placebo
Contacts
-
Public contact
- Full name: Fernando Comunello Schacher
-
- Address: Rua João Beruti, 160/303
- City: Porto Alegre / Brazil
- Zip code: 91330-370
- Phone: (51) 981958310
- Email: f_schacher@hotmail.com
- Affiliation: Hospital de Clínicas de Porto Alegre
- Full name: Fernando Comunello Schacher
-
- Address: Rua João Berutti, 160/303
- City: Porto Alegre / Brazil
- Zip code: 91330-370
- Phone: (55 51) 981958310
- Email: f_schacher@hotmail.com
- Affiliation: Hospital de Clínicas de Porto Alegre
-
Scientific contact
- Full name: Fernando Comunello Schacher
-
- Address: Rua João Berutti, 160/303
- City: Porto Alegre / Brazil
- Zip code: 91330-370
- Phone: (55 51) 981958310
- Email: f_schacher@hotmail.com
- Affiliation: Hospital de Clínicas de Porto Alegre
- Full name: Fernando Comunello Schacher
-
- Address: Rua João Beruti, 160/303
- City: Porto Alegre / Brazil
- Zip code: 91330-370
- Phone: (51) 981958310
- Email: f_schacher@hotmail.com
- Affiliation: Hospital de Clínicas de Porto Alegre
-
Site contact
- Full name: Fernando Comunello Schacher
-
- Address: Rua João Berutti, 160/303
- City: Porto Alegre / Brazil
- Zip code: 91330-370
- Phone: (55 51) 981958310
- Email: f_schacher@hotmail.com
- Affiliation: Hospital de Clínicas de Porto Alegre
- Full name: Fernando Comunello Schacher
-
- Address: Rua João Beruti, 160/303
- City: Porto Alegre / Brazil
- Zip code: 91330-370
- Phone: (51) 981958310
- Email: f_schacher@hotmail.com
- Affiliation: Hospital de Clínicas de Porto Alegre
Additional links:
Total de Ensaios Clínicos 16963.
Existem 8361 ensaios clínicos registrados.
Existem 4701 ensaios clínicos recrutando.
Existem 236 ensaios clínicos em análise.
Existem 5771 ensaios clínicos em rascunho.